Please login to the form below

Not currently logged in
Email:
Password:

isotretinoin

This page shows the latest isotretinoin news and features for those working in and with pharma, biotech and healthcare.

Recordati snaps up Swiss pharma company Pro Farma

Recordati snaps up Swiss pharma company Pro Farma

The firm sealed a deal with independent family-owned Swiss firm Pro Farma last week that was valued at CHF16m and will add to its portfolio the acne treatment Tretinac (isotretinoin)

Latest news

  • Therapy focus: acne

    Severe Acne drug. Now, there is a whole host of drugs, including the contraceptive pill and many herbal remedies, but one that has courted particular attention is isotretinoin (Roaccutane and Accutane), ... Treatment with this drug has had a high success

  • Alliance Pharma's profit up 17 per cent

    The products include acne treatment Rizuderm (isotretinoin). The move follows previous acquisitions for Alliance this year, including the pain relief therapy Anbesol (benzocaine).

  • Roche drug slapped with caveats

    The Food and Drug Administration (FDA) said it had approved a strengthened distribution programme for Accutane, also known under its generic name isotretinoin, requiring doctors and patients to register and accept

  • News in brief, April 04, 2007

    The FDA is launching a special webpage to warn consumers about the dangers of buying Accutane (isotretinoin) online.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    The product contains isotretinoin (Roaccutane) and has Orphan Drug Designation in the US. ... 50. Patagonia/ Almirall. PAT-001 (isotretinoin-based treatment) – congenital ichthyosis. Licence. 28.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics